Patient-reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life

Farah Bahbah¹, Catherine Gentil², Bernardo Sousa-Pinto^{3

4}, G Walter Canonica^{5

6}, Philippe Devillier⁷, Oliver Pfaar⁸, Jean Bousquet^{9

10

11}

Affiliations

¹ Stallergenes Greer Ltd, Antony, France.
² Axiodis, Toulouse, France.
³ Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
⁴ CINTESIS@RISE - Health Research Network, University of Porto, Porto, Portugal.
⁵ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
⁶ Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
⁷ VIM Suresnes, UMR_0892, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
⁸ Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
⁹ Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.
¹⁰ Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany.
¹¹ University Hospital Montpellier, Montpellier, France.

Farah Bahbah et al. Allergy. 2023 Apr.

. 2023 Apr;78(4):1113-1116.

doi: 10.1111/all.15550. Epub 2022 Oct 21.

Farah Bahbah¹, Catherine Gentil², Bernardo Sousa-Pinto^{3

4}, G Walter Canonica^{5

6}, Philippe Devillier⁷, Oliver Pfaar⁸, Jean Bousquet^{9

10

11}

¹ Stallergenes Greer Ltd, Antony, France.
² Axiodis, Toulouse, France.
³ Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
⁴ CINTESIS@RISE - Health Research Network, University of Porto, Porto, Portugal.
⁵ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
⁶ Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
⁷ VIM Suresnes, UMR_0892, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
⁸ Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
⁹ Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.
¹⁰ Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany.
¹¹ University Hospital Montpellier, Montpellier, France.

No abstract available

References

1. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21(1):77-83.
1. Worm M, Rak S, de Blay F, et al. Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study. Clin Transl Allergy. 2014;4(1):7.
1. Bakdash JZ, Marusich LR. Repeated measures correlation. Front Psychol. 2017;8:456.
1. Dramburg S, Perna S, Di Fraia M, et al. Heterogeneous validity of daily data on symptoms of seasonal allergic rhinitis recorded by patients using the e-diary AllergyMonitor®. Clin Transl Allergy. 2021;11(10):e12084.
1. Li AR, Zhang K, Reddy PD, et al. Systematic review of measures of disease severity in rhinitis. Int Forum Allergy Rhinol. 2021;11(9):1367-1377.